ArticleJournal for immunotherapy of cancer2025

Selective BCL-2 inhibitor triggers STING-dependent antitumor immunity via inducing mtDNA release.

Wenxin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.